Journal article
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
Abstract
BACKGROUND: Prevention and management of end-organ disease represent major challenges facing providers of children and adults with sickle cell disease (SCD). Uncertainty and variability in the screening, diagnosis, and management of cardiopulmonary and renal complications in SCD lead to varying outcomes for affected individuals.
OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support …
Authors
Liem RI; Lanzkron S; D. Coates T; DeCastro L; Desai AA; Ataga KI; Cohen RT; Haynes J; Osunkwo I; Lebensburger JD
Journal
Blood Advances, Vol. 3, No. 23, pp. 3867–3897
Publisher
American Society of Hematology
Publication Date
December 10, 2019
DOI
10.1182/bloodadvances.2019000916
ISSN
2473-9529